COMPOSTO NUCLEOSIDICO TERAPEUTICO

The present invention relates to (1R,4S)-4-(6-amino-9H-purin-9-yl)-2-cyclopentene-1-methanol and its use in medical therapy for the treatment of hepatitis B infection.

Saved in:
Bibliographic Details
Main Author SUSAN MARY DALUGE
Format Patent
LanguagePortuguese
Published 29.08.2003
Edition7
Subjects
Online AccessGet full text

Cover

Loading…
More Information
Summary:The present invention relates to (1R,4S)-4-(6-amino-9H-purin-9-yl)-2-cyclopentene-1-methanol and its use in medical therapy for the treatment of hepatitis B infection.
Bibliography:Application Number: PT20000902768T